(Q34096605)

English

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

multiple drug resistance

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

Enterobacteriaceae

0 references

author name string

Antonia C Kastoris

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Anastasios M Kapaskelis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

43-50

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Emerging antibiotic resistance in urinary tract pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-spectrum beta-lactamases: a clinical update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Current control and treatment of multidrug-resistant Acinetobacter baumannii infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fosfomycin: use beyond urinary tract and gastrointestinal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fosfomycin trometamol

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the Etest method for fosfomycin susceptibility of ESBL-producing Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: comparison of susceptibility testing procedures.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Etiology of community-acquired lower urinary infections and antimicrobial resistance of Escherichia coli: a national surveillance study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial resistance in Escherichia coli outpatient urinary isolates from women: emerging multidrug resistance phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutators among CTX-M beta-lactamase-producing Escherichia coli and risk for the emergence of fosfomycin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary tract infection caused by fluoroquinolone- and cephem-resistant Enterobacteriaceae.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged outbreak of infection due to TEM-21-producing strains of Pseudomonas aeruginosa and enterobacteria in a nursing home

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Life-threatening infantile diarrhea from fluoroquinolone-resistant Salmonella enterica typhimurium with mutations in both gyrA and parC.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lactose-fermenting, multiple drug-resistant Salmonella typhi strains isolated from a patient with postoperative typhoid fever

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasmid-encoded fosfomycin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fosfomycin and Plasmidic Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetic Localization of the Resistance to Fosfomycin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel Fosfomycin resistance of Pseudomonas aeruginosa clinical isolates recovered in Japan in 1996.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Formation of an adduct between fosfomycin and glutathione: a new mechanism of antibiotic resistance in bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro susceptibility of quinolone-resistant Enterobacteriaceae uropathogens to fosfomycin trometamol, in Dakar, Senegal

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-spectrum beta-lactamases in ambulatory care: a clinical perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended-spectrum beta-lactamase-producing organisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to fluoroquinolones and treatment failure/short-term relapse of community-acquired urinary tract infections caused by Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pivmecillinam?therapy of choice for lower urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of mecillinam against AmpC beta-lactamase-producing Escherichia coli.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Activity of mecillinam against ESBL producers in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinam.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Biological costs and mechanisms of fosfomycin resistance in Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fosfomycin tromethamine as second agent for the treatment of acute, uncomplicated urinary tract infections in adult female patients in The Netherlands?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro susceptibility testing procedures for fosfomycin tromethamine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Susceptibility testing quality control studies with fosfomycin tromethamine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970325-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(09)70325-1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20129148%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34096605&oldid=1621846699"